The study, led by Michael J. Mason of the University of Tennessee’s Center for Behavioral Health Research, recruited 102 young adults between the ages of 18 and 25 through social media. This age band matters epidemiologically: according to federal survey data cited by the team, more U.S. young adults report moderate to severe symptoms of generalized anxiety disorder and major depressive episodes than any other age group. The comorbidity figures are striking. Almost half of people with major depressive disorder will also experience generalized anxiety disorder, and roughly two-thirds of those with generalized anxiety disorder will experience major depression. Any treatment that can reach both conditions with a single, low-cost intervention could reshape how this population is served.

The trial design was a three-month randomized clinical trial comparing the automated texting program against a wait-list control condition. Participants in the treatment arm received CBT-txt-A, a program that had already demonstrated efficacy in treating generalized anxiety disorder in the team’s earlier work. Depression symptoms were measured with the PHQ-8, an eight-item instrument widely used to assess current depression in general populations. Using repeated measures analysis of variance, the researchers found significant differences between the treatment and wait-list conditions on depressive symptoms over time, producing a medium treatment effect of Cohen’s d equal to 0.61. In practical terms, a medium effect means the difference between groups was large enough to be clinically meaningful, not merely a statistical artifact.

Clinical significance testing, which goes beyond statistical significance to ask whether individual participants moved into healthier diagnostic ranges, reinforced the result. At the three-month follow-up, 27 percent of participants in the treatment group had no or minimal depressive symptoms, and an additional 33 percent had only mild symptoms. For an intervention that requires no therapist, no clinic visits, and no appointments, that proportion of participants reaching minimal or mild symptom levels is notable. The team frames the program as a potential low-burden support option for young adults in settings where access to conventional treatment is limited, whether because of cost, distance, workforce shortages, or stigma.

What elevates the study beyond a simple secondary-outcomes report is its analysis of mechanism. The researchers did not merely document that depression scores fell; they tested how the treatment produced those reductions. Drawing on the tradition of mediation analysis in psychotherapy research, they hypothesized three clinical pathways through which an anxiety-focused treatment could indirectly ease depression: increased behavioral activation, reduced perseverative thinking, and reduced cognitive distortion. All three hypotheses were supported. Participants in the treatment condition showed greater gains on each of these mechanisms relative to controls, and changes in each mechanism were associated with statistically significant reductions in depressive symptoms.

Each mechanism has a well-established theoretical pedigree. Behavioral activation, the process of re-engaging with rewarding and meaningful activities, is a core component of depression treatment, and the team measured it with the short form of the Behavioral Activation for Depression Scale. Perseverative thinking, the repetitive, content-independent negative thought loop that fuels both worry and rumination, was assessed with the Perseverative Thinking Questionnaire. Cognitive distortion, the systematic errors in thinking described in Aaron Beck’s foundational cognitive theory of depression, was measured with the Cognitive Distortions Scale. The finding that an anxiety treatment moved all three levers simultaneously lends empirical weight to the generic cognitive model, which holds that cognitive and behavioral change processes cut across emotional disorders rather than belonging to one diagnosis at a time.

This transdiagnostic interpretation is where the study connects to a broader shift in clinical psychology. Increasingly, researchers argue that anxiety and depression share common underlying processes, including repetitive negative thinking, avoidance, and maladaptive cognitions, and that treatments targeting those shared processes should produce crossover effects. The current results provide precisely that kind of evidence in a digital format. Prior trials by the same group found that CBT-txt-A reduced anxiety symptoms and, in a companion analysis, that a digital depression treatment produced secondary benefits for anxiety, which the authors describe as empirical support for the generic cognitive model. The new study completes the loop by demonstrating the reverse crossover: treating anxiety secondarily benefits depression.

The delivery mechanism itself is part of the scientific story. Text-message-delivered interventions sit within a growing family of digital mental health tools, including app-supported smartphone programs and internet-delivered psychotherapy, that meta-analyses have found effective across a range of common mental health problems. But CBT-txt-A differs from app-based approaches in an important way: it is automated and arrives in the messaging channel people already check constantly throughout the day. There is nothing to download, no login to remember, and no therapist waitlist to join. For young adults, a demographic that notoriously underuses traditional mental health services, embedding evidence-based therapeutic content into an everyday communication medium may lower the barriers that keep people from seeking help.

Recruitment through social media also deserves attention as a methodological feature. Rather than waiting for distressed young adults to find a clinic, the team met them on the platforms where they already spend time. This approach raises questions about sample representativeness that the researchers will need to address in future work, and the authors note that data will be made available upon request once the research team has completed all analyses. The trial was approved by the institutional review board of the University of Tennessee and funded by the Betsey R. Bush endowment for Children and Families at Risk and Behavioral Health Research at the university’s Center for Behavioral Health Research.

The mediation findings, in particular, point toward future refinements. If reductions in perseverative thinking, cognitive distortion, and increases in behavioral activation statistically account for the improvements in depression, then digital programs could be deliberately engineered to strengthen those specific ingredients rather than simply transplanting face-to-face protocols into text format. Mediation analysis of this kind also informs dosage questions: understanding which mechanisms activate earliest and most strongly could guide how program content is sequenced. The research team’s prior work testing mechanisms of change for text-message-delivered cognitive behavioral therapy in young adult depression laid the groundwork for the current mediation models, and the convergence of results across trials strengthens confidence that these are genuine change processes rather than statistical noise.

Limitations remain. The comparison condition was a wait-list rather than an active control, which means some of the observed effect could reflect nonspecific factors such as expectation or attention, although the presence of specific, hypothesized mediation pathways argues against a purely placebo interpretation. The three-month window captures short-term benefit, and longer follow-up will be needed to determine whether gains persist. The sample of 102 participants is adequate for the mediation models used but modest in absolute terms, and replication in larger and more diverse samples will be essential. Still, the combination of a medium effect size, a meaningful proportion of participants reaching minimal symptoms, and three empirically supported mechanisms of change makes a compelling case that automated texting programs can do more than their designers intended.

The practical implications are considerable. A program that requires no clinician time can be scaled at near-zero marginal cost, and if it simultaneously treats anxiety and reduces depression, it functions as a force multiplier for stretched mental health systems. For the millions of young adults experiencing comorbid anxiety and depression who never make it to a therapist’s office, a stream of carefully constructed text messages may be the only evidence-based intervention they ever receive. The study suggests that this unlikely delivery channel, powered by the same cognitive and behavioral mechanisms that drive traditional therapy, can produce clinically meaningful change, and that the boundary between treating one disorder and treating its most common companion may be far more permeable than diagnostic manuals imply.

Subject of Research: Secondary effects and clinical mechanisms of a text-message-delivered cognitive behavioral therapy for anxiety on depressive symptoms in young adults

Article Title: Secondary Effects and Mechanisms of Digital Anxiety Treatment on Depressive Symptoms: A Randomized Clinical Trial with Young Adults

Article References: Mason, M. J., Coatsworth, J. D., Zaharakis, N., Brown, A., Russell, M., & Mennis, J. (2026). Secondary Effects and Mechanisms of Digital Anxiety Treatment on Depressive Symptoms: A Randomized Clinical Trial with Young Adults. International Journal of Mental Health and Addiction. https://doi.org/10.1007/s11469-026-01733-0

Image Credits: AI Generated

DOI: 10.1007/s11469-026-01733-0

Keywords: digital mental health, text message therapy, cognitive behavioral therapy, generalized anxiety disorder, major depressive disorder, young adults, randomized clinical trial, behavioral activation, perseverative thinking, cognitive distortion, comorbidity, CBT-txt-A

The perspective, authored by Mehmet Kosa of Marshall University, Nora M. Barnes-Horowitz of the University of Colorado Boulder, and Michelle G. Craske of the University of California, Los Angeles, builds on a growing body of evidence that treatments specifically targeting reward sensitivity can meaningfully reduce anhedonia. Rather than treating low mood as a single undifferentiated problem, the authors argue that clinicians should think of anhedonia as a disorder of the reward system, one that can be systematically probed and retrained. Virtual reality, they contend, offers an unprecedented medium for doing exactly that, because it can deliver experiences that are specific, fine-tuned, immersive and personalized in ways that traditional talk therapy or flat-screen interventions cannot match.

The theoretical foundation of the proposal rests on decades of work dissecting how the brain processes reward. Neuroscientists have long distinguished between separable components of reward: ‘liking’, the hedonic pleasure experienced in the moment; ‘wanting’, the motivational drive that pushes an organism to seek out rewards; and learning, the process by which the brain updates its expectations about what is worth pursuing. These components rely on partially distinct neural circuits, and they can be impaired independently of one another. A person with anhedonia may be able to enjoy a pleasurable experience once they are fully engaged in it, yet lack the motivation to begin it, or they may fail to learn from positive outcomes that would normally encourage repetition. This fractionation matters clinically, because a treatment that boosts one component may do nothing for another.

At the heart of the new argument is a deceptively simple computational concept: the reward prediction error. When an outcome turns out better than expected, dopamine neurons in the ventral striatum and midbrain fire in a characteristic burst, signaling a positive prediction error. This signal is not merely a marker of pleasure; it is the engine of reinforcement learning, teaching the brain which actions and contexts are worth repeating. Decades of research, from classic animal studies to modern human neuroimaging, have established that these prediction error signals drive learning, memory encoding, attention and motivation. Crucially, work by Wolfram Schultz and others has shown that the magnitude of the dopamine response scales with the discrepancy between expected and obtained reward, not with the reward itself.

What makes this relevant to anhedonia is a growing literature suggesting that prediction error signaling is blunted in people with the symptom. Studies of reinforcement learning in depression have found flattened responses to unexpected rewards, and related work on internet gaming disorder has documented dampened prediction error signals as well. Meanwhile, computational models of momentary well-being, developed by Robb Rutledge and colleagues, indicate that fleeting happiness depends more on recent prediction errors than on the absolute size of rewards received. In other words, the emotional lift we feel in daily life may be driven less by what we get and more by how much better it was than we anticipated. If anhedonic individuals experience smaller positive prediction errors, the world may feel flat not because nothing good happens, but because nothing good surprises them.

This is where virtual reality enters the picture. The authors propose that carefully engineered VR interactions could be designed specifically to generate positive reward prediction errors, delivering outcomes that reliably and pleasantly exceed expectations. Unlike real life, where reward statistics are messy and uncontrollable, a virtual environment gives designers precise control over timing, probability, magnitude and surprise. A user might reach for a glowing object expecting a modest sparkle and instead trigger a cascading burst of color, sound and narrative payoff. Each such moment, the argument goes, delivers a clean, well-timed dopaminergic teaching signal to a reward system that has grown underresponsive. Over repeated exposures, these signals could gradually recalibrate reward sensitivity, strengthening the learning and motivational components of reward processing that are most impaired in anhedonia.

The second pillar of the proposal is equally ambitious: rather than treating VR as a single undifferentiated pleasure machine, the authors argue that distinct activities within a virtual experience should be mapped onto the distinct phases of reward processing. Anticipatory reward, the ‘wanting’ phase, could be targeted with activities that build expectation and motivation, such as quests, exploration and goal pursuit that require effortful engagement before any payoff arrives. Consummatory reward, the ‘liking’ phase, could be targeted with immersive savoring experiences, rich sensory environments and moments designed purely for in-the-moment enjoyment. Reward learning, meanwhile, could be targeted with probabilistic tasks and feedback structures that require the user to discover, through trial and error, which choices lead to better outcomes. This phase-specific design philosophy mirrors the structure of Positive Affect Treatment, the neuroscience-informed psychotherapy developed by Craske and colleagues, which has shown in multiple randomized controlled trials that directly targeting reward sensitivity can reduce anhedonia, depression and anxiety symptoms.

The evidence base for this approach is still young but encouraging. A pilot study of VR-based reward training for anhedonia demonstrated feasibility, and randomized trials of virtual reality-enhanced behavioral activation for major depressive disorder have shown promising results. Meta-analyses of VR exposure therapy for anxiety disorders have established that immersive technologies can produce clinically meaningful change, and systematic reviews of positive mood induction confirm that virtual environments can reliably elicit positive emotions. Research on presence, the subjective sense of ‘being there’ in a virtual world, suggests that immersion amplifies emotional responses, and studies of interactive media indicate that agency, the feeling that one’s actions matter, adds further emotional impact on top of immersion alone. Interactivity, the authors emphasize, is not a cosmetic feature: it is what allows the user to generate their own prediction errors through action, rather than passively receiving them.

The perspective also confronts the practical and ethical challenges honestly. VR sickness remains a barrier for some users, and validated questionnaires now exist to monitor it. Privacy and security concerns in immersive platforms are real, since these systems can collect intimate behavioral and physiological data. Ethical questions about children and adolescents, and about the risk that highly rewarding virtual experiences could shade into problematic use, particularly given what is known about gaming disorder, must be taken seriously. The authors call for adaptive designs that personalize difficulty and reward statistics to each user, rigorous measurement of presence and side effects, and careful attention to who benefits and who might be harmed.

If the vision succeeds, the implications could extend well beyond anhedonia. Objective measures of reward sensitivity are already being used to track treatment response, and neuroimaging work has linked ventral striatal reward activation to lasting improvements in life satisfaction. A VR platform that reliably elicits positive prediction errors and targets each reward phase could serve simultaneously as a clinical intervention, a research instrument and a personalized medicine tool, allowing clinicians to identify which component of reward processing is impaired in a given patient and to tune the virtual experience accordingly. The authors frame their contribution as a roadmap rather than a finished treatment, but the destination is clear: a future in which the brain’s pleasure circuits, dulled by illness, can be systematically and safely reawakened, one well-timed surprise at a time, inside a headset.

Subject of Research: Using interactive virtual reality to generate reward prediction errors and target anticipatory, consummatory and learning reward phases as a treatment approach for anhedonia.

Article Title: Reward prediction error and reward components in interactive virtual reality for anhedonia

Article References: Kosa, M., Barnes-Horowitz, N. M., & Craske, M. G. (2026). Reward prediction error and reward components in interactive virtual reality for anhedonia. Nature Mental Health. https://doi.org/10.1038/s44220-026-00731-4

Image Credits: AI Generated

DOI: 10.1038/s44220-026-00731-4

Keywords: anhedonia, virtual reality, reward prediction error, dopamine, reward sensitivity, positive affect treatment, reinforcement learning, ventral striatum, behavioral activation, mental health, immersive technology, depression